Mouse and rat plasma renin concentration and gene expression in (mRen2)27 transgenic rats

被引:22
作者
Bohlender, J [1 ]
Ménard, J [1 ]
Edling, O [1 ]
Ganten, D [1 ]
Luft, FC [1 ]
机构
[1] Humboldt Univ, Klinikum Rudolf Virchow, Max Delbruck Ctr Mol Med, D-13122 Berlin, Germany
来源
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY | 1998年 / 274卷 / 05期
关键词
renin gene expression; kidney; hypertension;
D O I
10.1152/ajpheart.1998.274.5.H1450
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The (mRen2)27 transgenic rat [TGR(mRen2)27] is said to have low plasma levels of active renin. We used a direct radioimmunoassay (RIA) for mouse submaxillary renin, as well as an indirect enzyme-kinetic assay based on the generation of angiotensin I with modification of the pH optimum, to measure rat and mouse plasma renin activity (PRA), plasma renin concentration (PRC), and plasma prorenin in TGR before and after lisinopril. The relationship between rat PRC and %rat kidney extract was steepest at pH 6.0 and flat at pH 8.5, whereas the relationship between mouse PRC and purified mouse renin was steepest at pH 8.5 and flat at pH 6.0. Mouse PRC was highly correlated with direct RIA measurements (r = 0.93). PRA before lisinopril was little influenced by pH, whereas the increase with lisinopril was greatest at pH 6.5. PRC before lisinopril was fourfold higher at pH 8.5 compared with that at pH 6.0. Lisinopril increased both PRC values but reversed the pH dependency. Prorenin was fourfold higher at pH 8.5 compared with that at pH 6.0 and decreased slightly with lisinopril. Renal renin concentration was higher at pH 6.0 than at pH 8.5. With Lisinopril, renal renin concentration increased at both pH values. Mouse PRC was not changed by lisinopril. Ribonuclease protection assay showed both rat and mouse renin gene expression in the kidney, which increased with lisinopril. Thus TGR have circulating active rat and mouse renin and prorenin. The notion that TGR are a "low renin" model should be revised.
引用
收藏
页码:H1450 / H1456
页数:7
相关论文
共 30 条
  • [1] AUFFRAY C, 1980, EUR J BIOCHEM, V107, P303
  • [2] TRANSGENIC RATS CARRYING THE MOUSE RENIN GENE - MORPHOLOGICAL CHARACTERIZATION OF A LOW-RENIN HYPERTENSION MODEL
    BACHMANN, S
    PETERS, J
    ENGLER, E
    GANTEN, D
    MULLINS, J
    [J]. KIDNEY INTERNATIONAL, 1992, 41 (01) : 24 - 36
  • [3] ROLE OF TISSUE RENIN IN THE PATHOPHYSIOLOGY OF HYPERTENSION IN TGR(MREN2)27 RATS
    BADER, M
    ZHAO, Y
    SANDER, M
    LEE, MA
    BACHMANN, J
    BOHM, M
    DJAVIDANI, B
    PETERS, J
    MULLINS, JJ
    GANTEN, D
    [J]. HYPERTENSION, 1992, 19 (06) : 681 - 686
  • [4] Human renin-dependent hypertension in rats transgenic for human angiotensinogen
    Bohlender, J
    Menard, J
    Wagner, J
    Luft, FC
    Ganten, D
    [J]. HYPERTENSION, 1996, 27 (03) : 535 - 540
  • [5] Dose effects of human renin in rats transgenic for human angiotensinogen
    Bohlender, J
    Menard, J
    Luft, FC
    Ganten, D
    [J]. HYPERTENSION, 1997, 29 (04) : 1031 - 1038
  • [6] DIRECT RADIOIMMUNOASSAY OF RAT ANGIOTENSINOGEN AND ITS APPLICATION TO RATS IN VARIOUS ENDOCRINE STATES
    BOUHNIK, J
    CLAUSER, E
    GARDES, J
    CORVOL, P
    MENARD, J
    [J]. CLINICAL SCIENCE, 1982, 62 (04) : 355 - 360
  • [7] ANGIOTENSIN AND BRADYKININ PEPTIDES IN THE TGR(MREN-2)27 RAT
    CAMPBELL, DJ
    RONG, P
    KLADIS, A
    REES, B
    GANTEN, D
    SKINNER, SL
    [J]. HYPERTENSION, 1995, 25 (05) : 1014 - 1020
  • [8] CHRONIC DEXAMETHASONE TREATMENT SUPPRESSES HYPERTENSION DEVELOPMENT IN THE TRANSGENIC RAT TGR(MREN2)27
    DJAVIDANI, B
    SANDER, M
    KREUTZ, R
    ZEH, K
    BADER, M
    MELLON, SH
    VECSEI, P
    PETERS, J
    GANTEN, D
    [J]. JOURNAL OF HYPERTENSION, 1995, 13 (06) : 637 - 645
  • [9] EFFECT OF CAPTOPRIL AND ANGIOTENSIN-II RECEPTOR BLOCKADE ON PRESSURE NATRIURESIS IN TRANSGENIC TGR(MREN-2)27 RATS
    GROSS, V
    LIPPOLDT, A
    SCHNEIDER, W
    LUFT, FC
    [J]. HYPERTENSION, 1995, 26 (03) : 471 - 479
  • [10] The hypertensive Ren-2 transgenic rat TGR(mREN2)27 in hypertension research - Characteristics and functional aspects
    Langheinrich, M
    Lee, MA
    Bohm, M
    Pinto, YM
    Ganten, D
    Paul, M
    [J]. AMERICAN JOURNAL OF HYPERTENSION, 1996, 9 (05) : 506 - 512